Back

Psychedelic Drug Stocks Jump After President Trump Orders Faster Review Process

President Trump signed an executive order directing health regulators to accelerate reviews of psychedelic drugs, lifting shares including Enveric Biosciences, Compass Pathways, and Dogwood Therapeutics.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Executive order: A directive issued by a president that instructs government agencies on how to carry out policy or administrative actions.
  • Health regulators: Government agencies that review the safety, efficacy, and approval process for drugs and other medical products.
  • Psychedelic drugs: A class of substances being studied for potential therapeutic use, including treatment of certain mental health conditions.